Showing results (421-430 of 516) with videos related to

Sort By:
Pageof 52
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 27, 2012
Post-load insulin resistance does not predict virological response to treatment of chronic hepatitis C patients without the metabolic syndromeGiovanna Fattovich, Gianluca Svegliati Baroni, Michela Pasino, et al.
Journal of Adolescent and Young Adult Oncology|August 8, 2020
Impact of Rhabdomyosarcoma Treatment Modalities by Age in a Population-Based SettingAndrea Ferrari, Alice Bernasconi, Luca Bergamaschi, et al.
Gut|October 23, 2010
Insulin resistance and necroinflammation drives ductular reaction and epithelial-mesenchymal transition in chronic hepatitis CGianluca Svegliati-Baroni, Graziella Faraci, Luca Fabris, et al.
British Journal of Cancer|November 2, 2016
MicroRNA 193b-3p as a predictive biomarker of chronic kidney disease in patients undergoing radical nephrectomy for renal cell carcinomaFrancesco Trevisani, Michele Ghidini, Alessandro Larcher, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|December 14, 2006
Activation of the IGF1 system characterizes cholangiocyte survival during progression of primary biliary cirrhosisPaolo Onori, Domenico Alvaro, Anna Rosa Floreani, et al.
The Journal of Pediatrics|February 14, 2003
Hepatitis C virus infection associated with liver-kidney microsomal antibody type 1 (LKM1) autoantibodies in childrenFlavia Bortolotti, Luigi Muratori, Paloma Jara, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|February 18, 2005
Isoniazid-related fulminant hepatic failure in a child: assessment of the native liver's early regeneration after auxiliary partial orthotopic liver transplantationUmberto Cillo, Marco Bassanello, Alessandro Vitale, et al.
Communications Biology|February 23, 2022
Hemojuvelin deficiency promotes liver mitochondrial dysfunction and predisposes mice to hepatocellular carcinomaAbdolamir Allameh, Nico Hüttmann, Edouard Charlebois, et al.
Expert Opinion on Investigational Drugs|February 24, 2021
Targeted therapies for extrahepatic cholangiocarcinoma: preclinical and clinical development and prospects for the clinicMassimiliano Cadamuro, Alberto Lasagni, Angela Lamarca, et al.
Pageof 52